CAS RN: 1031927-02-2

3-Amino-4-imidazo[1,2-a]pyrazin-2-yl-1,2,5-oxadiazole

Product Availability

Choose a grade to view its available package options.

4 package records3 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260331 100mg In stock Shanghai Inquiry
Batchno.20250615 1g In stock Shanghai Inquiry
Batchno.20251222 250mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260319 25mg / 100mg / 250mg / 1g Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS1031927-02-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1031927-02-2 / 4-imidazo[1,2-a]pyrazin-2-yl-1,2,5-oxadiazol-3-amine

4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine | MFCD11035755 | 4-imidazo[1,2-a]pyrazin-2-yl-1,2,5-oxadiazol-3-amine

Standard CAS: 1031927-02-2 Multi CAS: No

Basic Information

CAS
1031927-02-2
Multi CAS
No
Molecular Formula
C8H6N6O
Molecular Weight
202.170000
Exact Mass
202.060309
SMILES
C1=CN2C=C(N=C2C=N1)C3=NON=C3N
InChI
InChI=1S/C8H6N6O/c9-8-7(12-15-13-8)5-4-14-2-1-10-3-6(14)11-5/h1-4H,(H2,9,13)
InChIKey
YZWLTQHMDOCNGL-UHFFFAOYSA-N
Synonyms
4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine MFCD11035755 4-imidazo[1,2-a]pyrazin-2-yl-1,2,5-oxadiazol-3-amine C8H6N6O 3-AMINO-4-IMIDAZO[1,2-A]PYRAZIN-2-YL-1,2,5-OXADIAZOLE

Computed Properties

Structural Parameters

Heavy atom count
15
Aromatic heavy atom count
14
Rotatable bonds
1
H-bond acceptors
7
H-bond donors
1
Molar refractivity
50.69
TPSA
95.13

LogP / Solubility

WLOGP
0.36
MLOGP
0.32
XLogP3
-0.1
Consensus LogP
0.19
Log S (ESOL)
-1.95
Class (ESOL)
Soluble
Log S (Ali)
-1.48
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.39
Class (SILICOS-IT)
Soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.7

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5

Get In Touch

Contact Us